These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8497279)

  • 1. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.
    Kerppola TK; Luk D; Curran T
    Mol Cell Biol; 1993 Jun; 13(6):3782-91. PubMed ID: 8497279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun.
    Leonard DA; Rajaram N; Kerppola TK
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4913-8. PubMed ID: 9144164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of the orientation of Fos-Jun binding and the transcriptional cooperativity of Fos-Jun-NFAT1 complexes.
    Ramirez-Carrozzi VR; Kerppola TK
    J Biol Chem; 2001 Jun; 276(24):21797-808. PubMed ID: 11259418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive and negative modulation of Jun action by thyroid hormone receptor at a unique AP1 site.
    Lopez G; Schaufele F; Webb P; Holloway JM; Baxter JD; Kushner PJ
    Mol Cell Biol; 1993 May; 13(5):3042-9. PubMed ID: 8474460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK; Curran T
    Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
    Chatton B; Bocco JL; Goetz J; Gaire M; Lutz Y; Kedinger C
    Oncogene; 1994 Feb; 9(2):375-85. PubMed ID: 8290251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing actions of Fos and Jun on transcription of the phosphoenolpyruvate carboxykinase (GTP) gene. Dominant negative regulation by Fos.
    Gurney AL; Park EA; Giralt M; Liu J; Hanson RW
    J Biol Chem; 1992 Sep; 267(25):18133-9. PubMed ID: 1325459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of alpha-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site.
    Zhang XK; Dong JM; Chiu JF
    J Biol Chem; 1991 May; 266(13):8248-54. PubMed ID: 1708774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1.
    Diefenbacher M; Sekula S; Heilbock C; Maier JV; Litfin M; van Dam H; Castellazzi M; Herrlich P; Kassel O
    Mol Endocrinol; 2008 Aug; 22(8):1767-80. PubMed ID: 18535250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric recognition of nonconsensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1.
    Ramirez-Carrozzi V; Kerppola T
    Mol Cell Biol; 2003 Mar; 23(5):1737-49. PubMed ID: 12588992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity.
    Kerppola TK; Curran T
    Cell; 1991 Jul; 66(2):317-26. PubMed ID: 1906785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain swapping reveals the modular nature of Fos, Jun, and CREB proteins.
    Ransone LJ; Wamsley P; Morley KL; Verma IM
    Mol Cell Biol; 1990 Sep; 10(9):4565-73. PubMed ID: 2143806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive regulation of the skeletal alpha-actin gene by Fos and Jun in cardiac myocytes.
    Bishopric NH; Jayasena V; Webster KA
    J Biol Chem; 1992 Dec; 267(35):25535-40. PubMed ID: 1460048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.
    Sato H; Takeshita H; Furukawa M; Seiki M
    J Virol; 1992 Aug; 66(8):4732-6. PubMed ID: 1321269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation by Fos and Jun in vitro: interaction among multiple activator and regulatory domains.
    Abate C; Luk D; Curran T
    Mol Cell Biol; 1991 Jul; 11(7):3624-32. PubMed ID: 1904542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
    Barrett TJ; Vedeckis WV
    Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun.
    Kataoka K; Noda M; Nishizawa M
    Mol Cell Biol; 1994 Jan; 14(1):700-12. PubMed ID: 8264639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA bending by Fos-Jun and the orientation of heterodimer binding depend on the sequence of the AP-1 site.
    Rajaram N; Kerppola TK
    EMBO J; 1997 May; 16(10):2917-25. PubMed ID: 9184235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.